The Latin America, Middle East and Africa Enteral Syringe Market is projected to witness market growth of 6.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Enteral Syringe Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $10.32 millions by 2031. The Argentina market is showcasing a CAGR of 8.1% during 2024-2031. Additionally, the UAE market would register a CAGR of 5.9% during 2024-2031.
The expansion of healthcare facilities and the increasing availability of enteral nutrition products in developing regions have led to a greater adoption of these syringes. Improved healthcare infrastructure supports better patient access to these essential devices. Investment in modern medical equipment, including these syringes, is rising. Governments and private entities invest in healthcare infrastructure to enhance patient care and support adopting advanced medical technologies.
Modern syringes are designed with safety features such as anti-backflow technology and secure connectors to prevent contamination and ensure accurate delivery. These features enhance patient safety and encourage their use in clinical settings. These syringes designed for ease of use, including those with ergonomic handles and smooth plunger action, improve the overall patient experience and make them more appealing to healthcare providers.
The rising healthcare budget in the UAE is leading to the expansion of healthcare facilities, including hospitals and specialized clinics. This expansion necessitates the procurement of medical equipment and supplies, including these syringes, to meet the growing demand for healthcare services. Increased funding allows for the modernization and upgrading of medical infrastructure, which includes enhancing the availability and quality of these syringes. This ensures that healthcare providers have access to the latest and most efficient enteral feeding solutions. According to the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. With a growing elderly demographic, there is a higher incidence of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders. These conditions often require enteral nutrition, driving demand for these syringes. The increase in the elderly population leads to more long-term care facilities, such as nursing homes and assisted living centres, which require enteral syringes for patients who need ongoing nutritional support. Hence, increasing healthcare budget and rising elder population in the region is driving the growth of the market.
Based on Age Group, the market is segmented into Adults and Pediatrics. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare. Based on Type, the market is segmented into Disposable and Reusable. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Enteral Syringe Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $10.32 millions by 2031. The Argentina market is showcasing a CAGR of 8.1% during 2024-2031. Additionally, the UAE market would register a CAGR of 5.9% during 2024-2031.
The expansion of healthcare facilities and the increasing availability of enteral nutrition products in developing regions have led to a greater adoption of these syringes. Improved healthcare infrastructure supports better patient access to these essential devices. Investment in modern medical equipment, including these syringes, is rising. Governments and private entities invest in healthcare infrastructure to enhance patient care and support adopting advanced medical technologies.
Modern syringes are designed with safety features such as anti-backflow technology and secure connectors to prevent contamination and ensure accurate delivery. These features enhance patient safety and encourage their use in clinical settings. These syringes designed for ease of use, including those with ergonomic handles and smooth plunger action, improve the overall patient experience and make them more appealing to healthcare providers.
The rising healthcare budget in the UAE is leading to the expansion of healthcare facilities, including hospitals and specialized clinics. This expansion necessitates the procurement of medical equipment and supplies, including these syringes, to meet the growing demand for healthcare services. Increased funding allows for the modernization and upgrading of medical infrastructure, which includes enhancing the availability and quality of these syringes. This ensures that healthcare providers have access to the latest and most efficient enteral feeding solutions. According to the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. With a growing elderly demographic, there is a higher incidence of chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders. These conditions often require enteral nutrition, driving demand for these syringes. The increase in the elderly population leads to more long-term care facilities, such as nursing homes and assisted living centres, which require enteral syringes for patients who need ongoing nutritional support. Hence, increasing healthcare budget and rising elder population in the region is driving the growth of the market.
Based on Age Group, the market is segmented into Adults and Pediatrics. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare. Based on Type, the market is segmented into Disposable and Reusable. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Boston Scientific Corporation
- Nestlé S.A.
- Fresenius SE & Co. KGaA
- Becton, Dickinson and Company
- Braun Melsungen AG
- Cardinal Health, Inc.
- Moog Inc.
- Cook Medical, Inc.(Cook Group)
- Thermo Fisher Scientific Inc.
- Medela AG
Market Report Segmentation
By Age Group
- Adults
- Pediatrics
By End User
- Hospitals
- Ambulatory Surgical Centers
- Homecare
By Type
- Disposable
- Reusable
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Enteral Syringe Market by Age Group
Chapter 5. LAMEA Enteral Syringe Market by End User
Chapter 6. LAMEA Enteral Syringe Market by Type
Chapter 7. LAMEA Enteral Syringe Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- Nestlé S.A.
- Fresenius SE & Co. KGaA
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Moog Inc.
- Cook Medical, Inc.(Cook Group)
- Thermo Fisher Scientific Inc.
- Medela AG
Methodology
LOADING...
